Literature DB >> 27778162

Low testosterone and myasthenia gravis in males: a national record-linkage study.

Julia Pakpoor1, Raph Goldacre1, Michael J Goldacre2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27778162     DOI： 10.1007/s00415-016-8319-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  The epidemiology of myasthenia gravis.

Authors:  Lawrence H Phillips
Journal:  Semin Neurol       Date:  2004-03       Impact factor: 3.420

2.  Effect of testosterone on muscle mass and muscle protein synthesis.

Authors:  R C Griggs; W Kingston; R F Jozefowicz; B E Herr; G Forbes; D Halliday
Journal:  J Appl Physiol (1985)       Date:  1989-01

3.  Hypogonadism and the risk of rheumatic autoimmune disease.

Authors:  Jacques Baillargeon; Soham Al Snih; Mukaila A Raji; Randall J Urban; Gulshan Sharma; Melinda Sheffield-Moore; David S Lopez; Gwen Baillargeon; Yong-Fang Kuo
Journal:  Clin Rheumatol       Date:  2016-06-20       Impact factor: 2.980

Review 4.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

5.  Testicular hypofunction and multiple sclerosis risk: a record-linkage study.

Authors:  Julia Pakpoor; Raph Goldacre; Klaus Schmierer; Gavin Giovannoni; Michael J Goldacre
Journal:  Ann Neurol       Date:  2014-08-30       Impact factor: 10.422

6.  46,XY hypergonadotropic hypogonadism and myasthenia gravis.

Authors:  Corina Lichiardopol; V Herlea; Virginia Ioan; V Tomulescu; F Mixich
Journal:  Rom J Morphol Embryol       Date:  2006       Impact factor: 1.033

7.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

Authors:  Henry A Feldman; Christopher Longcope; Carol A Derby; Catherine B Johannes; Andre B Araujo; Andrea D Coviello; William J Bremner; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Authors:  Florian Kurth; Eileen Luders; Nancy L Sicotte; Christian Gaser; Barbara S Giesser; Ronald S Swerdloff; Michael J Montag; Rhonda R Voskuhl; Allan Mackenzie-Graham
Journal:  Neuroimage Clin       Date:  2014-03-06       Impact factor: 4.881

9.  HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.

Authors:  Julian Gold; Raph Goldacre; Hubert Maruszak; Gavin Giovannoni; David Yeates; Michael Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-04       Impact factor: 10.154
  9 in total
  1 in total

1.  Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility.

Authors:  Hui Deng; Jianjian Wang; Xiaotong Kong; Huixue Zhang; Tianfeng Wang; Wenqi Tian; Tingting Yi; Lihua Wang
Journal:  BMC Med Genet       Date:  2019-10-30       Impact factor: 2.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.